{"hands_on_practices": [{"introduction": "The crosstalk between eicosanoid and endocannabinoid signaling pathways often begins at the level of enzymatic synthesis, where a single enzyme may process substrates from both families. This exercise [@problem_id:2573953] explores such a scenario with Cyclooxygenase-2 (COX-2), which can oxygenate both arachidonic acid (AA) and 2-arachidonoylglycerol (2-AG). By applying the concept of catalytic efficiency ($k_{\\text{cat}}/K_m$), you will determine how an enzyme partitions its activity between two competing substrates, a fundamental principle that governs metabolic flux and pathway selection in vivo.", "problem": "Cyclooxygenase-2 (COX-2) catalyzes the oxygenation of arachidonic acid ($\\mathrm{AA}$) to prostaglandin $\\mathrm{E}_{2}$ ($\\mathrm{PGE}_{2}$) and the oxygenation of $2$-arachidonoylglycerol ($\\mathrm{2\\text{-}AG}$) to prostaglandin $\\mathrm{E}_{2}$ glycerol ester ($\\mathrm{PGE}_{2}\\text{-}\\mathrm{G}$). Under inflammatory conditions, assume steady-state initial velocity conditions with a single active site, and that both $\\mathrm{AA}$ and $\\mathrm{2\\text{-}AG}$ are present simultaneously and are each at concentrations much lower than their respective Michaelis constants (Michaelis constant denoted $K_{m}$). The catalytic efficiency $k_{\\text{cat}}/K_{m}$ of COX-2 for $\\mathrm{AA}$ is measured as $8.0 \\times 10^{5}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}$, and for $\\mathrm{2\\text{-}AG}$ as $3.2 \\times 10^{5}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}$. Cellular free concentrations are measured as $[\\mathrm{AA}] = 5.0\\ \\mu\\mathrm{M}$ and $[\\mathrm{2\\text{-}AG}] = 0.50\\ \\mu\\mathrm{M}$.\n\nStarting only from foundational enzyme kinetics principles (the steady-state Michaelis–Menten framework and the definition of catalytic efficiency), derive an expression for the ratio of the instantaneous production rates of $\\mathrm{PGE}_{2}$ to $\\mathrm{PGE}_{2}\\text{-}\\mathrm{G}$ when both substrates are present together, and then compute this ratio using the given values. Express your final answer as a dimensionless number corresponding to $\\mathrm{PGE}_{2}:\\mathrm{PGE}_{2}\\text{-}\\mathrm{G}$, rounded to three significant figures.", "solution": "The problem is first validated for scientific soundness and logical consistency.\n\n**Step 1: Extracted Givens**\n- Enzyme: Cyclooxygenase-2 (COX-2)\n- Substrate 1 ($\\mathrm{S_A}$): Arachidonic acid ($\\mathrm{AA}$)\n- Product 1 ($\\mathrm{P_A}$): Prostaglandin $\\mathrm{E}_{2}$ ($\\mathrm{PGE}_{2}$)\n- Substrate 2 ($\\mathrm{S_G}$): $2$-arachidonoylglycerol ($\\mathrm{2\\text{-}AG}$)\n- Product 2 ($\\mathrm{P_G}$): Prostaglandin $\\mathrm{E}_{2}$ glycerol ester ($\\mathrm{PGE}_{2}\\text{-}\\mathrm{G}$)\n- Conditions: Steady-state initial velocity, single active site, both substrates present simultaneously.\n- Approximations: $[\\mathrm{AA}] \\ll K_{m, \\mathrm{AA}}$ and $[\\mathrm{2\\text{-}AG}] \\ll K_{m, \\mathrm{2\\text{-}AG}}$\n- Catalytic efficiency for $\\mathrm{AA}$: $(\\frac{k_{\\text{cat}}}{K_{m}})_{\\mathrm{AA}} = 8.0 \\times 10^{5}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}$\n- Catalytic efficiency for $\\mathrm{2\\text{-}AG}$: $(\\frac{k_{\\text{cat}}}{K_{m}})_{\\mathrm{2\\text{-}AG}} = 3.2 \\times 10^{5}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}$\n- Concentration of $\\mathrm{AA}$: $[\\mathrm{AA}] = 5.0\\ \\mu\\mathrm{M} = 5.0 \\times 10^{-6}\\ \\mathrm{M}$\n- Concentration of $\\mathrm{2\\text{-}AG}$: $[\\mathrm{2\\text{-}AG}] = 0.50\\ \\mu\\mathrm{M} = 0.50 \\times 10^{-6}\\ \\mathrm{M}$\n- Objective: Derive the ratio of production rates $\\frac{v_{\\mathrm{PGE}_{2}}}{v_{\\mathrm{PGE}_{2}\\text{-}\\mathrm{G}}}$ and compute its numerical value.\n\n**Step 2: Validation Verdict**\nThe problem is scientifically grounded, describing a standard competitive substrate scenario in enzyme kinetics. The provided data are biochemically plausible, and the question is well-posed, with sufficient information for a unique solution. The language is objective and precise. The problem is deemed **valid**.\n\n**Derivation and Solution**\nWe begin from the foundational principles of steady-state enzyme kinetics for two competing substrates acting on a single enzyme active site. Let the enzyme be $E$, the substrates be $\\mathrm{S_A}$ (for $\\mathrm{AA}$) and $\\mathrm{S_G}$ (for $\\mathrm{2\\text{-}AG}$), and the corresponding products be $\\mathrm{P_A}$ and $\\mathrm{P_G}$. The reactions are:\n$$E + \\mathrm{S_A} \\underset{k_{-1,A}}{\\stackrel{k_{1,A}}{\\rightleftharpoons}} ES_A \\stackrel{k_{\\text{cat},A}}{\\longrightarrow} E + \\mathrm{P_A}$$\n$$E + \\mathrm{S_G} \\underset{k_{-1,G}}{\\stackrel{k_{1,G}}{\\rightleftharpoons}} ES_G \\stackrel{k_{\\text{cat},G}}{\\longrightarrow} E + \\mathrm{P_G}$$\n\nThe instantaneous initial velocities ($v$) for the formation of each product are defined by the breakdown of the respective enzyme-substrate complex:\n$$v_A = v_{\\mathrm{PGE}_2} = k_{\\text{cat},A} [ES_A]$$\n$$v_G = v_{\\mathrm{PGE}_2\\text{-G}} = k_{\\text{cat},G} [ES_G]$$\nwhere $[ES_A]$ and $[ES_G]$ are the steady-state concentrations of the enzyme-substrate complexes, and $k_{\\text{cat},A}$ and $k_{\\text{cat},G}$ are the catalytic rate constants for each reaction.\n\nThe problem requires the ratio of these two rates:\n$$\\frac{v_A}{v_G} = \\frac{k_{\\text{cat},A} [ES_A]}{k_{\\text{cat},G} [ES_G]}$$\n\nTo determine the concentrations of the complexes, we apply the steady-state approximation. The rate of formation of each complex is equal to its rate of breakdown:\n$$k_{1,A} [E] [\\mathrm{S_A}] = (k_{-1,A} + k_{\\text{cat},A}) [ES_A]$$\n$$k_{1,G} [E] [\\mathrm{S_G}] = (k_{-1,G} + k_{\\text{cat},G}) [ES_G]$$\nwhere $[E]$ is the concentration of the free, unbound enzyme.\n\nBy definition, the Michaelis constant $K_m$ is $K_m = \\frac{k_{-1} + k_{\\text{cat}}}{k_{1}}$. Rearranging the steady-state equations gives:\n$$[ES_A] = \\frac{k_{1,A}}{k_{-1,A} + k_{\\text{cat},A}} [E] [\\mathrm{S_A}] = \\frac{[E] [\\mathrm{S_A}]}{K_{m,A}}$$\n$$[ES_G] = \\frac{k_{1,G}}{k_{-1,G} + k_{\\text{cat},G}} [E] [\\mathrm{S_G}] = \\frac{[E] [\\mathrm{S_G}]}{K_{m,G}}$$\n\nNow substitute these expressions for $[ES_A]$ and $[ES_G]$ into the equation for the ratio of velocities:\n$$\\frac{v_A}{v_G} = \\frac{k_{\\text{cat},A} \\left( \\frac{[E] [\\mathrm{S_A}]}{K_{m,A}} \\right)}{k_{\\text{cat},G} \\left( \\frac{[E] [\\mathrm{S_G}]}{K_{m,G}} \\right)}$$\n\nThe concentration of free enzyme, $[E]$, cancels from the numerator and denominator. This is a crucial step, showing that the ratio of rates for competing substrates depends only on their concentrations and the enzyme's kinetic parameters for each, not on the total enzyme concentration. This yields the general expression for the ratio of rates of two competing substrates:\n$$\\frac{v_A}{v_G} = \\frac{\\left( \\frac{k_{\\text{cat},A}}{K_{m,A}} \\right) [\\mathrm{S_A}]}{\\left( \\frac{k_{\\text{cat},G}}{K_{m,G}} \\right) [\\mathrm{S_G}]}$$\n\nThe term $\\frac{k_{\\text{cat}}}{K_m}$ is the catalytic efficiency, or specificity constant. This constant represents the apparent second-order rate constant for the reaction between the enzyme and the substrate at low substrate concentrations. The derived expression shows that the partitioning of the enzyme between two substrates, and thus the ratio of their product formation rates, is determined by the ratio of the products of catalytic efficiency and substrate concentration.\n\nThe problem states that $[\\mathrm{S}] \\ll K_m$ for both substrates. This condition signifies that the enzyme is far from saturation, and the concentration of free enzyme $[E]$ is approximately equal to the total enzyme concentration $[E]_{\\text{total}}$. In this regime, the initial velocity for each reaction simplifies to $v \\approx \\frac{k_{\\text{cat}}}{K_m} [S] [E]$, which is a bimolecular reaction. The condition confirms that we are in the kinetic domain where catalytic efficiency is the correct parameter to compare substrate preference.\n\nWe now substitute the given values into the derived formula. Let S_A be $\\mathrm{AA}$ and S_G be $\\mathrm{2\\text{-}AG}$.\n$$(\\frac{k_{\\text{cat}}}{K_{m}})_{\\mathrm{AA}} = 8.0 \\times 10^{5}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}$$\n$$[\\mathrm{AA}] = 5.0 \\times 10^{-6}\\ \\mathrm{M}$$\n$$(\\frac{k_{\\text{cat}}}{K_{m}})_{\\mathrm{2\\text{-}AG}} = 3.2 \\times 10^{5}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}$$\n$$[\\mathrm{2\\text{-}AG}] = 0.50 \\times 10^{-6}\\ \\mathrm{M}$$\n\nThe ratio of the production rates, $\\frac{v_{\\mathrm{PGE}_{2}}}{v_{\\mathrm{PGE}_{2}\\text{-}\\mathrm{G}}}$, is:\n$$\\frac{v_{\\mathrm{PGE}_{2}}}{v_{\\mathrm{PGE}_{2}\\text{-}\\mathrm{G}}} = \\frac{(8.0 \\times 10^{5}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}) \\times (5.0 \\times 10^{-6}\\ \\mathrm{M})}{(3.2 \\times 10^{5}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}) \\times (0.50 \\times 10^{-6}\\ \\mathrm{M})}$$\n\nThe units cancel, resulting in a dimensionless ratio. The powers of $10$ also cancel:\n$$\\frac{v_{\\mathrm{PGE}_{2}}}{v_{\\mathrm{PGE}_{2}\\text{-}\\mathrm{G}}} = \\frac{8.0 \\times 5.0}{3.2 \\times 0.50} = \\frac{40}{1.6} = \\frac{400}{16} = 25$$\n\nThe problem requires the answer to be rounded to three significant figures. The calculated value of $25$ is exact. To express this with three significant figures, we write it as $25.0$. This indicates that the production of $\\mathrm{PGE}_{2}$ from $\\mathrm{AA}$ is $25.0$ times faster than the production of $\\mathrm{PGE}_{2}\\text{-}\\mathrm{G}$ from $\\mathrm{2\\text{-}AG}$ under the given conditions.", "answer": "$$\\boxed{25.0}$$", "id": "2573953"}, {"introduction": "Having seen how an enzyme chooses between endogenous substrates, we now turn to how we can pharmacologically influence these pathways. This problem [@problem_id:2573939] models the action of ibuprofen, a classic competitive inhibitor of cyclooxygenase (COX) enzymes, which are the primary targets of non-steroidal anti-inflammatory drugs (NSAIDs). You will apply Michaelis–Menten kinetics to a system with two distinct enzyme isoforms and dynamic substrate levels to quantify the impact of a reversible inhibitor on the overall rate of prostaglandin synthesis.", "problem": "Cyclooxygenase (COX) isoforms convert arachidonic acid (AA) to prostaglandin H2 (PGH2). Consider two isoforms, cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), operating under conditions where oxygen is saturating and each catalytic turnover produces exactly one PGH2 molecule. Assume standard steady-state Michaelis–Menten kinetics applies for a single-substrate reaction and that ibuprofen behaves as a purely competitive inhibitor with respect to AA, altering only the apparent substrate affinity. The cell experiences two quasi-steady AA plateaus during signaling and spends a fixed fraction of time at each plateau. The total PGH2 production rate is the sum of the rates from the two isoforms at a given AA level, and the time-averaged PGH2 production rate is the time-fraction-weighted sum across the two AA plateaus.\n\nParameters:\n- COX-1: $k_{\\text{cat},1} = 8\\,\\mathrm{s}^{-1}$, $K_{m,1} = 5\\,\\mu\\mathrm{M}$, $[E_1]_T = 50\\,\\mathrm{nM}$, $K_{i,1} = 0.5\\,\\mu\\mathrm{M}$.\n- COX-2: $k_{\\text{cat},2} = 12\\,\\mathrm{s}^{-1}$, $K_{m,2} = 2\\,\\mu\\mathrm{M}$, $[E_2]_T = 30\\,\\mathrm{nM}$, $K_{i,2} = 8\\,\\mu\\mathrm{M}$.\n- Arachidonic acid plateaus and time fractions: $[S]_1 = 2\\,\\mu\\mathrm{M}$ with $f_1 = 0.7$; $[S]_2 = 20\\,\\mu\\mathrm{M}$ with $f_2 = 0.3$.\n- Ibuprofen concentration during inhibition: $[I] = 5\\,\\mu\\mathrm{M}$.\n\nTasks:\n1. Using the assumptions above, compute the time-averaged steady-state PGH2 production rate in $\\mathrm{nM}\\,\\mathrm{s}^{-1}$ in the absence of ibuprofen.\n2. Compute the time-averaged steady-state PGH2 production rate in $\\mathrm{nM}\\,\\mathrm{s}^{-1}$ in the presence of ibuprofen at $[I] = 5\\,\\mu\\mathrm{M}$, accounting for competitive inhibition at each isoform with its respective $K_i$.\n3. Let $r$ denote the fractional reduction in the time-averaged PGH2 production rate due to ibuprofen, defined by $r = \\dfrac{\\bar{J}_{\\text{no\\_inh}} - \\bar{J}_{\\text{inh}}}{\\bar{J}_{\\text{no\\_inh}}}$. Report $r$ as a unitless decimal.\n\nExpress the final requested quantity $r$ as a decimal rounded to four significant figures. Do not include units in your final answer.", "solution": "We start from the steady-state Michaelis–Menten framework for a single-substrate enzyme system. For an enzyme with total active-site concentration $[E]_T$, catalytic constant $k_{\\text{cat}}$, and Michaelis constant $K_m$, the steady-state turnover rate for substrate concentration $[S]$ is\n$$\nv = \\frac{k_{\\text{cat}}\\,[E]_T\\,[S]}{K_m + [S]}.\n$$\nFor purely competitive inhibition by an inhibitor at concentration $[I]$ with inhibition constant $K_i$, the effect is to increase the apparent substrate Michaelis constant to\n$$\nK_m^{\\text{app}} = K_m\\left(1 + \\frac{[I]}{K_i}\\right),\n$$\nwhile leaving $k_{\\text{cat}}$ unchanged. The inhibited rate is therefore\n$$\nv_{\\text{inh}} = \\frac{k_{\\text{cat}}\\,[E]_T\\,[S]}{K_m^{\\text{app}} + [S]} = \\frac{k_{\\text{cat}}\\,[E]_T\\,[S]}{K_m\\left(1 + \\frac{[I]}{K_i}\\right) + [S]}.\n$$\nAt a given $[S]$, the total PGH2 production rate is the sum over isoforms:\n$$\nJ([S]) = \\sum_{i=1}^{2} \\frac{k_{\\text{cat},i}\\,[E_i]_T\\,[S]}{K_{m,i} + [S]},\n\\quad\nJ_{\\text{inh}}([S]) = \\sum_{i=1}^{2} \\frac{k_{\\text{cat},i}\\,[E_i]_T\\,[S]}{K_{m,i}\\left(1 + \\frac{[I]}{K_{i,i}}\\right) + [S]}.\n$$\nWith two AA plateaus $[S]_1$ and $[S]_2$ occurring with time fractions $f_1$ and $f_2$ (with $f_1 + f_2 = 1$), the time-averaged production rates are\n$$\n\\bar{J} = f_1\\,J([S]_1) + f_2\\,J([S]_2),\n\\qquad\n\\bar{J}_{\\text{inh}} = f_1\\,J_{\\text{inh}}([S]_1) + f_2\\,J_{\\text{inh}}([S]_2).\n$$\n\nCompute the uninhibited rates at $[S]_1 = 2\\,\\mu\\mathrm{M}$ and $[S]_2 = 20\\,\\mu\\mathrm{M}$.\n\nFor COX-1 ($k_{\\text{cat},1} = 8\\,\\mathrm{s}^{-1}$, $[E_1]_T = 50\\,\\mathrm{nM}$, $K_{m,1} = 5\\,\\mu\\mathrm{M}$):\n- At $[S]_1$: \n$$\nv_{1,\\text{no}}(2) = \\frac{8 \\times 50\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}\\times 2}{5 + 2}\n= 400\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}\\times \\frac{2}{7}\n= \\frac{800}{7}\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}.\n$$\n- At $[S]_2$:\n$$\nv_{1,\\text{no}}(20) = \\frac{8 \\times 50\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}\\times 20}{5 + 20}\n= 400\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}\\times \\frac{20}{25}\n= 320\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}.\n$$\n\nFor COX-2 ($k_{\\text{cat},2} = 12\\,\\mathrm{s}^{-1}$, $[E_2]_T = 30\\,\\mathrm{nM}$, $K_{m,2} = 2\\,\\mu\\mathrm{M}$):\n- At $[S]_1$:\n$$\nv_{2,\\text{no}}(2) = \\frac{12 \\times 30\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}\\times 2}{2 + 2}\n= 360\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}\\times \\frac{2}{4}\n= 180\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}.\n$$\n- At $[S]_2$:\n$$\nv_{2,\\text{no}}(20) = \\frac{12 \\times 30\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}\\times 20}{2 + 20}\n= 360\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}\\times \\frac{20}{22}\n= \\frac{3600}{11}\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}.\n$$\n\nSum to obtain total rates at each plateau:\n$$\nJ_{\\text{no}}(2) = \\frac{800}{7} + 180 = \\frac{2060}{7}\\,\\mathrm{nM}\\,\\mathrm{s}^{-1},\n\\quad\nJ_{\\text{no}}(20) = 320 + \\frac{3600}{11} = \\frac{7120}{11}\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}.\n$$\nTime-average with $f_1 = 0.7 = \\frac{7}{10}$ and $f_2 = 0.3 = \\frac{3}{10}$:\n$$\n\\bar{J}_{\\text{no}} = \\frac{7}{10}\\cdot \\frac{2060}{7} + \\frac{3}{10}\\cdot \\frac{7120}{11}\n= \\frac{2060}{10} + \\frac{21360}{110}\n= 206 + \\frac{2136}{11}\n= \\frac{4402}{11}\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}.\n$$\n\nNow include ibuprofen at $[I] = 5\\,\\mu\\mathrm{M}$. Compute apparent $K_m$ values using $K_m^{\\text{app}} = K_m\\left(1 + \\frac{[I]}{K_i}\\right)$:\n- COX-1: $K_{m,1}^{\\text{app}} = 5\\left(1 + \\frac{5}{0.5}\\right)\\,\\mu\\mathrm{M} = 5 \\times 11 = 55\\,\\mu\\mathrm{M}$.\n- COX-2: $K_{m,2}^{\\text{app}} = 2\\left(1 + \\frac{5}{8}\\right)\\,\\mu\\mathrm{M} = 2 \\times 1.625 = 3.25\\,\\mu\\mathrm{M}$.\n\nInhibited rates:\n\nCOX-1:\n- At $[S]_1$:\n$$\nv_{1,\\text{inh}}(2) = \\frac{8 \\times 50\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}\\times 2}{55 + 2}\n= 400\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}\\times \\frac{2}{57}\n= \\frac{800}{57}\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}.\n$$\n- At $[S]_2$:\n$$\nv_{1,\\text{inh}}(20) = 400\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}\\times \\frac{20}{55 + 20}\n= 400 \\times \\frac{20}{75}\n= \\frac{320}{3}\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}.\n$$\n\nCOX-2:\n- At $[S]_1$:\n$$\nv_{2,\\text{inh}}(2) = 360\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}\\times \\frac{2}{3.25 + 2}\n= \\frac{720}{5.25}\n= \\frac{2880}{21}\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}.\n$$\n- At $[S]_2$:\n$$\nv_{2,\\text{inh}}(20) = 360\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}\\times \\frac{20}{3.25 + 20}\n= \\frac{7200}{23.25}\n= \\frac{28800}{93}\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}.\n$$\n\nTotals at each plateau:\n$$\nJ_{\\text{inh}}(2) = \\frac{800}{57} + \\frac{2880}{21}\n= \\frac{5600}{399} + \\frac{54720}{399}\n= \\frac{60320}{399}\\,\\mathrm{nM}\\,\\mathrm{s}^{-1},\n$$\n$$\nJ_{\\text{inh}}(20) = \\frac{320}{3} + \\frac{28800}{93}\n= \\frac{9920}{93} + \\frac{28800}{93}\n= \\frac{38720}{93}\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}.\n$$\n\nTime-average:\n$$\n\\bar{J}_{\\text{inh}} = \\frac{7}{10}\\cdot \\frac{60320}{399} + \\frac{3}{10}\\cdot \\frac{38720}{93}\n= \\frac{42224}{399} + \\frac{3872}{31}.\n$$\nBring to a common denominator $12369 = 399 \\times 31$:\n$$\n\\bar{J}_{\\text{inh}} = \\frac{42224 \\cdot 31}{12369} + \\frac{3872 \\cdot 399}{12369}\n= \\frac{1308944 + 1544928}{12369}\n= \\frac{2853872}{12369}\n= \\frac{407696}{1767}\\,\\mathrm{nM}\\,\\mathrm{s}^{-1}.\n$$\n\nCompute the fractional reduction\n$$\nr = \\frac{\\bar{J}_{\\text{no}} - \\bar{J}_{\\text{inh}}}{\\bar{J}_{\\text{no}}}\n= 1 - \\frac{\\bar{J}_{\\text{inh}}}{\\bar{J}_{\\text{no}}}\n= 1 - \\frac{\\frac{407696}{1767}}{\\frac{4402}{11}}\n= 1 - \\frac{407696 \\cdot 11}{1767 \\cdot 4402}\n= 1 - \\frac{4484656}{7778334}\n= \\frac{7778334 - 4484656}{7778334}\n= \\frac{3293678}{7778334}.\n$$\nReduce by a factor of $2$:\n$$\nr = \\frac{1646839}{3889167} \\approx 0.4234426\\ldots\n$$\nRounded to four significant figures:\n$$\nr \\approx 0.4234.\n$$\nPer the instructions, we report $r$ as a unitless decimal rounded to four significant figures.", "answer": "$$\\boxed{0.4234}$$", "id": "2573939"}, {"introduction": "The biological impact of lipid mediators is ultimately determined by their interactions with specific receptors. This practice problem [@problem_id:2573935] shifts our focus from synthesis to the signaling event itself, modeling the competition between the two primary endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), at the CB1 receptor. By deriving and applying the principles of competitive ligand binding, you will calculate how receptor occupancy and signaling amplitude are determined by the interplay of ligand concentrations, binding affinities ($K_d$), and intrinsic efficacies.", "problem": "Cannabinoid receptor type 1 (CB1) is a G protein-coupled receptor that binds the endogenous ligands anandamide (N-arachidonoylethanolamine, AEA) and 2-arachidonoylglycerol (2-AG). Consider a membrane preparation in which CB1 is at total receptor concentration (also called the maximal specific binding capacity) $B_{\\max}$, with both AEA and 2-AG present and competing for a single orthosteric site. Assume rapid equilibrium, a single class of noninteracting binding sites, and purely competitive binding between the two ligands.\n\nYou are given the following experimentally determined parameters and conditions:\n- Dissociation constant for AEA: $K_d^{\\mathrm{AEA}} = 0.80~\\mu\\mathrm{M}$.\n- Dissociation constant for 2-AG: $K_d^{\\mathrm{2AG}} = 0.040~\\mu\\mathrm{M}$.\n- Total receptor concentration: $B_{\\max} = 0.150~\\mu\\mathrm{M}$.\n- Ligand concentrations: $[\\mathrm{AEA}] = 0.200~\\mu\\mathrm{M}$ and $[\\mathrm{2AG}] = 0.100~\\mu\\mathrm{M}$.\n- Intrinsic efficacies (unitless, relative to a full agonist): $\\alpha_{\\mathrm{AEA}} = 0.50$ and $\\alpha_{\\mathrm{2AG}} = 1.00$.\n\nStarting only from the law of mass action, the definition of the dissociation constant $K_d$ as $K_d = \\frac{[R][L]}{[RL]}$ for each ligand, and conservation of receptor mass $[R_T] = [R] + \\sum_i [RL_i]$, derive expressions for the fractional occupancies of CB1 by AEA and by 2-AG at equilibrium when both ligands are present, and the resulting normalized signaling amplitude defined as the weighted sum of fractional occupancies by intrinsic efficacies. Specifically, define the normalized signaling amplitude as $A_{\\mathrm{norm}} = \\alpha_{\\mathrm{AEA}} f_{\\mathrm{AEA}} + \\alpha_{\\mathrm{2AG}} f_{\\mathrm{2AG}}$, where $f_i$ is the fraction of total receptor occupied by ligand $i$. Treat $A_{\\mathrm{norm}}$ as dimensionless by normalizing to the response when all receptors are occupied by 2-AG.\n\nCompute numerically the fractional occupancies $f_{\\mathrm{AEA}}$ and $f_{\\mathrm{2AG}}$, and $A_{\\mathrm{norm}}$ under the given conditions. Report your final answer as a row matrix $\\begin{pmatrix} f_{\\mathrm{AEA}} & f_{\\mathrm{2AG}} & A_{\\mathrm{norm}} \\end{pmatrix}$, expressed as dimensionless fractions and rounded to $4$ significant figures. Do not include units in your reported row matrix.", "solution": "The problem is subjected to validation before any attempt at a solution.\n\nStep 1: Extract Givens\nThe provided parameters and definitions are as follows:\n- Dissociation constant for anandamide (AEA): $K_d^{\\mathrm{AEA}} = 0.80~\\mu\\mathrm{M}$.\n- Dissociation constant for 2-arachidonoylglycerol (2-AG): $K_d^{\\mathrm{2AG}} = 0.040~\\mu\\mathrm{M}$.\n- Total receptor concentration: $B_{\\max} = [R_T] = 0.150~\\mu\\mathrm{M}$.\n- Ligand concentrations: $[\\mathrm{AEA}] = 0.200~\\mu\\mathrm{M}$ and $[\\mathrm{2AG}] = 0.100~\\mu\\mathrm{M}$. These are assumed to be the free equilibrium concentrations.\n- Intrinsic efficacies: $\\alpha_{\\mathrm{AEA}} = 0.50$ and $\\alpha_{\\mathrm{2AG}} = 1.00$.\n- Fundamental definitions: $K_d = \\frac{[R][L]}{[RL]}$ for each ligand.\n- Conservation of receptor mass: $[R_T] = [R] + \\sum_i [RL_i]$.\n- Definition of fractional occupancy: $f_i = \\frac{[RL_i]}{[R_T]}$.\n- Definition of normalized signaling amplitude: $A_{\\mathrm{norm}} = \\alpha_{\\mathrm{AEA}} f_{\\mathrm{AEA}} + \\alpha_{\\mathrm{2AG}} f_{\\mathrm{2AG}}$.\n\nStep 2: Validate Using Extracted Givens\nThe problem is scientifically grounded, being a standard application of competitive ligand binding theory based on the law of mass action. It is well-posed, providing all necessary information for a unique solution. The language is objective and precise. The parameters are biochemically plausible. The model described is a cornerstone of receptor pharmacology. There are no violations of scientific principles, logical inconsistencies, or ambiguities.\n\nStep 3: Verdict and Action\nThe problem is deemed valid. A solution will be derived from first principles as requested.\n\nThe system involves a single receptor, $R$, that can bind two different ligands, AEA and 2-AG, at the same site. We denote AEA as ligand $L_1$ and 2-AG as ligand $L_2$. The binding reactions at equilibrium are:\n$R + L_1 \\rightleftharpoons RL_1$\n$R + L_2 \\rightleftharpoons RL_2$\n\nAccording to the law of mass action, the dissociation constants are defined as:\n$$K_{d1} = K_d^{\\mathrm{AEA}} = \\frac{[R][L_1]}{[RL_1]}$$\n$$K_{d2} = K_d^{\\mathrm{2AG}} = \\frac{[R][L_2]}{[RL_2]}$$\nHere, $[R]$ is the concentration of free receptors, $[L_1]$ and $[L_2]$ are the free concentrations of AEA and 2-AG, respectively, and $[RL_1]$ and $[RL_2]$ are the concentrations of the receptor-ligand complexes.\n\nThe concentrations of the receptor-ligand complexes can be expressed in terms of the free receptor concentration $[R]$:\n$$[RL_1] = \\frac{[R][L_1]}{K_{d1}}$$\n$$[RL_2] = \\frac{[R][L_2]}{K_{d2}}$$\n\nThe total concentration of receptors, $[R_T]$ (given as $B_{\\max}$), is the sum of the free receptors and all bound forms. For this two-ligand system, the conservation of receptor mass is:\n$$[R_T] = [R] + [RL_1] + [RL_2]$$\n\nSubstitute the expressions for $[RL_1]$ and $[RL_2]$ into the conservation equation:\n$$[R_T] = [R] + \\frac{[R][L_1]}{K_{d1}} + \\frac{[R][L_2]}{K_{d2}}$$\n\nFactor out the free receptor concentration $[R]$:\n$$[R_T] = [R] \\left( 1 + \\frac{[L_1]}{K_{d1}} + \\frac{[L_2]}{K_{d2}} \\right)$$\n\nThe fractional occupancy of the receptor by ligand $L_1$ (AEA) is defined as $f_1 = \\frac{[RL_1]}{[R_T]}$. We substitute our expression for $[RL_1]$:\n$$f_1 = \\frac{1}{[R_T]} \\left( \\frac{[R][L_1]}{K_{d1}} \\right)$$\n\nFrom the factored conservation equation, we can express $[R]$ as $[R] = \\frac{[R_T]}{1 + \\frac{[L_1]}{K_{d1}} + \\frac{[L_2]}{K_{d2}}}$. Substituting this into the expression for $f_1$:\n$$f_1 = \\frac{1}{[R_T]} \\left( \\frac{[R_T]}{1 + \\frac{[L_1]}{K_{d1}} + \\frac{[L_2]}{K_{d2}}} \\cdot \\frac{[L_1]}{K_{d1}} \\right)$$\nSimplifying this expression yields the fractional occupancy for AEA:\n$$f_{\\mathrm{AEA}} = f_1 = \\frac{\\frac{[L_1]}{K_{d1}}}{1 + \\frac{[L_1]}{K_{d1}} + \\frac{[L_2]}{K_{d2}}}$$\n\nBy an identical derivation, the fractional occupancy for 2-AG ($L_2$) is:\n$$f_{\\mathrm{2AG}} = f_2 = \\frac{\\frac{[L_2]}{K_{d2}}}{1 + \\frac{[L_1]}{K_{d1}} + \\frac{[L_2]}{K_{d2}}}$$\nThese are the general equations for fractional occupancy in a two-ligand competitive binding system. It is noteworthy that the total receptor concentration $B_{\\max}$ does not appear in these expressions for fractional quantities. The provided value $B_{\\max} = 0.150~\\mu\\mathrm{M}$ is not required for this part of the calculation, assuming the given ligand concentrations are free equilibrium concentrations.\n\nNow, we substitute the given numerical values:\n- $[L_1] = [\\mathrm{AEA}] = 0.200~\\mu\\mathrm{M}$\n- $K_{d1} = K_d^{\\mathrm{AEA}} = 0.80~\\mu\\mathrm{M}$\n- $[L_2] = [\\mathrm{2AG}] = 0.100~\\mu\\mathrm{M}$\n- $K_{d2} = K_d^{\\mathrm{2AG}} = 0.040~\\mu\\mathrm{M}$\n\nFirst, calculate the dimensionless concentration ratios:\n$$\\frac{[L_1]}{K_{d1}} = \\frac{0.200}{0.80} = 0.25$$\n$$\\frac{[L_2]}{K_{d2}} = \\frac{0.100}{0.040} = 2.5$$\n\nThe common denominator is:\n$$1 + \\frac{[L_1]}{K_{d1}} + \\frac{[L_2]}{K_{d2}} = 1 + 0.25 + 2.5 = 3.75$$\n\nNow, we compute the fractional occupancies:\n$$f_{\\mathrm{AEA}} = \\frac{0.25}{3.75} = \\frac{1}{15} \\approx 0.066666...$$\n$$f_{\\mathrm{2AG}} = \\frac{2.5}{3.75} = \\frac{10}{15} = \\frac{2}{3} \\approx 0.666666...$$\n\nRounding to $4$ significant figures:\n$f_{\\mathrm{AEA}} = 0.06667$\n$f_{\\mathrm{2AG}} = 0.6667$\n\nFinally, we compute the normalized signaling amplitude, $A_{\\mathrm{norm}}$, using the given formula and intrinsic efficacies $\\alpha_{\\mathrm{AEA}} = 0.50$ and $\\alpha_{\\mathrm{2AG}} = 1.00$. The problem states that $A_{\\mathrm{norm}}$ is normalized to the response when all receptors are occupied by 2-AG. The maximum response from 2-AG is $\\alpha_{\\mathrm{2AG}} \\times 1 = 1.00$. The given formula $A_{\\mathrm{norm}} = \\alpha_{\\mathrm{AEA}} f_{\\mathrm{AEA}} + \\alpha_{\\mathrm{2AG}} f_{\\mathrm{2AG}}$ is thus already normalized to this maximum possible response for a full agonist with $\\alpha=1$.\n\n$$A_{\\mathrm{norm}} = (\\alpha_{\\mathrm{AEA}})(f_{\\mathrm{AEA}}) + (\\alpha_{\\mathrm{2AG}})(f_{\\mathrm{2AG}})$$\n$$A_{\\mathrm{norm}} = (0.50) \\left( \\frac{1}{15} \\right) + (1.00) \\left( \\frac{10}{15} \\right)$$\n$$A_{\\mathrm{norm}} = \\frac{0.5}{15} + \\frac{10}{15} = \\frac{10.5}{15} = 0.7$$\n\nRounding to $4$ significant figures, $A_{\\mathrm{norm}} = 0.7000$.\n\nThe final results are the fractional occupancies for AEA and 2-AG, and the normalized signaling amplitude.", "answer": "$$\\boxed{\\begin{pmatrix} 0.06667 & 0.6667 & 0.7000 \\end{pmatrix}}$$", "id": "2573935"}]}